TSOI .0591 BIG NEWS All Content and Data provided by

New Post Public Reply Private Reply Replies (0) Message Board
FLA
42
TSOI .0591 BIG NEWS


All Content and Data provided by Third-Parties — Terms of Use
Therapeutic Solutions International Prepares to Apply for Emergency Use Authorization (EUA) for its FDA Phase III COVID-19 Stem Cell Therapy JadiCell™Integrated Immunotherapy Company Seeks to Expand Access to Unique "Living Anti-inflammatory" Therapy Which Previously Demonstrated Potent Preclinical and Clinical Results in COVID-19
PR NEWSWIRE 9:00 AM ET 8/16/2021
Symbol Last Price Change
TSOI 0.0591down 0 (0%)
QUOTES AS OF 12:00:00 AM ET 08/13/2021
ELK CITY, Idaho , Aug. 16, 2021 /PRNewswire/ -- Therapeutic Solutions International, Inc.(TSOI), , announced today initiation of preparation for filing an Emergency Use Authorization (EUA) to the FDA for JadiCells™ in treatment of COVID-19 associated lung injury.

The EUA is a mechanism that allows FDA to help strengthen the nation's public health protections against threats such as infectious diseases by facilitating the availability and use of medical countermeasures (MCMs) needed during public health emergencies. Under this provision, the FDA may authorize unapproved medical products to be used in an emergency to treat serious or life-threatening diseases or conditions.

"The extremely promising preclinical data we are generating, as well as the previously published double blind FDA clinical trial and most recently, FDA clearance to enter Phase III, strongly supports the rationale to file for Emergency Use Authorization" said Dr. James Veltmeyer, Chief Medical Officer of the Company. "As a practicing physician, myself and my colleagues are eager to begin using these cells and potentially saving lives".

In previous studies the Company has demonstrated the superior activity of JadiCell™ to other types of stem cells including bone marrow, adipose, cord blood, and placenta. Furthermore, in an FDA double blind clinical trial the JadiCell™ was shown to be 100% effective in saving the lives of COVID-19 ICU patients1 under the age of 85. On August 5th, 2021, the FDA granted clearance for initiation of a Phase III pivotal trial using JadiCells to treat COVID-192.

"We are thankful to our Advisory Board, which includes Dr. Francesco Marincola, World Wide Head of Cell Therapy Research for Gilead, and Dr. Santosh Kesari, Principle Investigator on other stem cell trials for COVID-19, for bringing decades of national and international expertise in dealing with regulatory bodies in fast-tracking approval of cellular and gene therapies in helping us to make this monumental decision" said Timothy Dixon, President and CEO of Therapeutic Solutions International(TSOI). "Given the urgent nature of the ongoing pandemic, and the early suggestions that our cells are effective against the delta variant, we are exploring and pursuing all possible avenues to bring JadiCells to the patients that need them now."

About Therapeutic Solutions International, Inc.(TSOI)
Therapeutic Solutions International (TSOI) is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com, and our public forum is https://board.therapeuticsolutionsint.com/

1 Umbilical cord mesenchymal stem cells for COVID–19 acute respiratory distress syndrome: A double–blind, phase 1/2a, randomized controlled trial - Lanzoni - 2021 - STEM CELLS Translational Medicine - Wiley Online Library

2 Therapeutic Solutions International Receives FDA Clearance to Initiate Phase III Pivotal Registration Trial for JadiCell™ Universal Donor COVID-19 Therapy (prnewswire.com)

Contact:
ir@tsoimail.com



Cision View original content:https://www.prnewswire.com/news-releases/therapeutic-solutions-international-prepares-to-apply-for-emergency-use-authorization-eua-for-its-fda-phase-iii-covid-19-stem-cell-therapy-jadicell-301355728.html

SOURCE Therapeutic Solutions International(TSOI)

















TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI TSOI
I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rosti Group Expands with Alvi Acquisition

Updated Category News Views 139

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 0

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 98

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 57

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 119

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Bybit Expands On-Chain Access: Japanese Equity Focus

Updated Category News Views 71

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 109

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Biond's BND-67 Trial: New Hope Against Tumors

Updated Category News Views 55

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Continue Reading
Foundayo Aims to Revolutionize Sleep Apnea Treatment

Updated Category News Views 81

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Continue Reading

Top 5 Most Recently Viewed Articles

Sulliden Mining Capital's Annual Meeting Results Unveiled

Updated Category News Views 159

Sulliden Mining Capital's Annual Meeting Results Unveiled On June 30, 2025, Sulliden Mining Capital Inc. (TSX: SMC) held its Annual and Special Meeting of Shareholders. This event followed the guidelines established by the Toronto Stock Exchange. During the meeting, shareholders engaged in an essential process—electing nominees presented in the management information...

Continue Reading
Ascential Medical's Dynamic Leadership Changes for Growth

Updated Category News Views 348

Leadership Changes at Ascential Medical & Life Sciences Ellen Scipta and Chris Cowen are stepping into pivotal roles as CFO and CCO at Ascential Medical & Life Sciences, while Todd Martensen transitions to the role of CSO. These changes reflect the company's commitment to innovation and strategic growth. Introducing Ellen Scipta: New Chief Financial Officer Ellen Scipta...

Continue Reading
Investors Target Xerox Holdings for Securities Class Action

Updated Category News Views 201

Legal Investigation of Xerox Holdings Corporation Faruqi & Faruqi, LLP, a highly regarded national securities law firm, is currently investigating potential claims involving Xerox Holdings Corporation (NASDAQ: XRX). Investors who have suffered significant financial losses are encouraged to reach out to discuss options available to them. Investor Losses and Legal Options...

Continue Reading
Understanding the Risks of Sharing Back-to-School Photos

Updated Category News Views 240

Understanding the Risks of Sharing Back-to-School Photos As families across the nation prepare for a new school year, there’s an important reminder from experienced investigator and child advocate, Moses Castillo. Before sharing those back-to-school photos on social media, it's crucial to consider the potential dangers associated with such posts. The Hidden Dangers of...

Continue Reading
Intel's Journey: Overcoming Two Decades of Market Struggles

Updated Category News Views 111

Intel's Long Road to Recovery Intel has faced significant challenges over the past two decades. Its stock performance has been lackluster, rising only 2% compared to the NASDAQ 100, which has surged over 1,200%. This stark contrast raises questions about Intel's strategic decisions and future direction. Intel's leadership has stumbled in crucial areas that have allowed...

Continue Reading